Clinical Trial Update: Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pembrolizumab with hypofractionated radiation therapy for mucosal melanoma of the head and neck and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma of the Head and Neck

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Mucosal Melanoma of the Head and Neck | Phase 2 | Status: RECRUITING